ABCC6: A Promising Drug Target and Biomarker for Multiple Sclerosis

Target Name: ABCC6

NCBI ID: G368

ABCC6

ABCC6: A Promising Drug Target and Biomarker for Multiple Sclerosis

Multiple sclerosis (MS) is a chronic autoimmune disease that affects millions of people worldwide. The immune system attacks the central nervous system, leading to muscle weakness, stiffness, and vision loss. There are currently no cure-lasting treatments available for MS, and the disease often progresses to a progressive and life-threatening form.

ABCC6, a transmembrane protein expressed in various tissues, has been identified as a potential drug target and biomarker for MS. This protein plays a crucial role in the regulation of mitochondrial function, which is crucial for the survival of immune cells. ABCC6 has been shown to modulate the immune response and contribute to the pathogenesis of MS.

The Diverse Roles of ABCC6 in Cellular Functions

ABCC6 is a member of the superfamily of transmembrane proteins, which consists of proteins that span the cell membrane and extend into the cytoplasm. These proteins are involved in various cellular processes, including signaling, ion transport, and storage of molecules.

One of the well-documented functions of ABCC6 is its role in mitochondrial function. It is a key protein in the regulation of mitochondrial outer membrane conductance (MOM), which is the ability of mitochondria to export ions and molecules across the membrane. MOM is critical for maintaining the stability of cellular processes, including energy production and the control of pH levels.

ABCC6 is also involved in the regulation of mitochondrial dynamics. It plays a role in the trafficking of mitochondrial proteins to and from the mitochondria, which is crucial for maintaining the proper functioning of these organelles.

In addition to its role in mitochondrial function, ABCC6 has been shown to participate in various signaling pathways. It has been shown to interact with various cytokines and signaling molecules, including TGF-β, NF-kappa-B, and AP-1. These interactions may play a role in the regulation of cellular processes, including inflammation and stress responses.

The Potential Role of ABCC6 as a Drug Target

The identification of ABCC6 as a potential drug target is based on its involvement in various cellular processes that are crucial for the development and progression of MS. Several studies have shown that modulating ABCC6 function may be a promising approach for the development of new treatments for MS.

One of the potential benefits of targeting ABCC6 is its potential to modulate the immune response. ABCC6 has been shown to play a role in the regulation of T cell function, which is crucial for the immune response. Modulating ABCC6 function may be a way to dampen the immune response and reduce the risk of progression to a progressive and life-threatening form of MS.

Another potential benefit of targeting ABCC6 is its potential to modulate inflammation. ABCC6 has been shown to play a role in the regulation of pro-inflammatory cytokine production and the modulation of inflammation. Targeting ABCC6 may be a way to reduce inflammation and improve the efficacy of current treatments for MS.

ABCC6 also has been shown to play a role in the regulation of cellular stress responses. It has been shown to interact with various stress-responsive molecules, including p62, which is a key transcription factor that regulates stress responses in cells. Targeting ABCC6 may be a way to improve the cellular stress response and reduce the risk of cellular damage in response to stressors.

The Potential Role of ABCC6 as a Biomarker

ABCC6 has also been shown to be a potential biomarker for MS. The regulation of ABCC6 function may be a way to diagnose and monitor the progression of MS. Several studies have shown that changes in ABCC6 function may be associated with the development and progression of MS.

In addition to its potential as a drug target

Protein Name: ATP Binding Cassette Subfamily C Member 6

Functions: ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds, and xenobiotics from cells. Mediates ATP-dependent transport of glutathione conjugates such as leukotriene-c4 (LTC4) and N-ethylmaleimide S-glutathione (NEM-GS) (in vitro), and an anionic cyclopentapeptide endothelin antagonist, BQ-123 (PubMed:11880368, PubMed:12414644). May contribute to regulate the transport of organic compounds in testes across the blood-testis-barrier (Probable). Does not appear to actively transport drugs outside the cell. Confers low levels of cellular resistance to etoposide, teniposide, anthracyclines and cisplatin (PubMed:12414644)

The "ABCC6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ABCC6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets